Pediatric Cardiology News

At 10 years, transcatheter pulmonary valve replacement provided sustained symptomatic and hemodynamic improvement in most patients with complex congenital heart disease, data from the Melody investigational device exemption trial indicated.

Childhood abuse was associated with certain negative cardiometabolic outcomes at different ages in young adults, according to study data published in the Journal of the American Heart Association.

Age at pediatric stroke has a significant impact on post-stroke recovery and affects long-term cognitive outcome regardless of lesion size and lesion location, according to results of a cross-sectional study published in Neurology.

There have been rare reports of myocarditis and pericarditis among people who have received a COVID-19 messenger RNA vaccine, with cases occurring especially among male adolescents and young adults, according to the CDC.

FDA approved rivaroxaban in tablet form and as an oral suspension to treat and reduce the risk for recurrence of venous thromboembolism among certain populations of children.

Edwards Lifesciences announced it received FDA approval for its transcatheter valve with adaptive prestent for patients with severe pulmonary regurgitation.

Extracardiac anomalies, including structural brain anomalies, were frequently detected on fetal MRI among fetuses with various forms of congenital heart disease, researchers reported.

Most young people under the age of 21 years with suspected myocarditis following COVID-19 vaccination had mild symptoms that resolved quickly, according to data published in Circulation.

Cardiologs announced it received 510(k) clearance from the FDA for use of its artificial intelligence-powered cardiac diagnostics platform in pediatric cardiology.

In children and adolescents with latent rheumatic heart disease, secondary antibiotic prophylaxis was associated with lower risk for disease progression at 2 years, researchers reported at the American Heart Association Scientific Sessions.